Pharmallama and Shark Tank investors warned of legal action for violations of norms

Share via:

An association of pharmaceutical distributors has warned the startup and all investors of legal ramifications after epharmacy Pharmallama received funding from multiple investors on the TV show Shark Tank India.

Pharmallama runs a ‘full-service pharmacy and comprehensive medication management platform,’ delivering medication to users in pre-sorted sachets. The South Chemists and Distributors Association (SCDA) of Delhi claimed in a letter to the startup’s founders and the Health Ministry that Pharmallama’s operations are illegal and should be shut down immediately in the public interest. The SCDA claimed in its letter that operating an epharmacy is against Indian law. Furthermore, no rule allowing repacking of medicines has yet been formulated in the country.

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

Pharmallama and Shark Tank investors warned of legal action for violations of norms

An association of pharmaceutical distributors has warned the startup and all investors of legal ramifications after epharmacy Pharmallama received funding from multiple investors on the TV show Shark Tank India.

Pharmallama runs a ‘full-service pharmacy and comprehensive medication management platform,’ delivering medication to users in pre-sorted sachets. The South Chemists and Distributors Association (SCDA) of Delhi claimed in a letter to the startup’s founders and the Health Ministry that Pharmallama’s operations are illegal and should be shut down immediately in the public interest. The SCDA claimed in its letter that operating an epharmacy is against Indian law. Furthermore, no rule allowing repacking of medicines has yet been formulated in the country.

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

What brokerages think of HCLTech’s Q4 deal wins, tariff...

Analysts' reactions to HCLTechnologies' March quarter results were...

‘Don’t break Google’: Perplexity AI CEO offers alternative ahead...

Perplexity AI and OpenAI have been asked to...

Gensol Engineering promoters’ stake more than halves amid Sebi...

Gensol Engineering promoters' saw their shareholding more than...

Popular

Upcoming Events

Now, BluSmart Ropes In Grant Thornton For Forensic Audit

SUMMARY EV ride-hailing startup BluSmart has roped in Grant...

Ather IPO: Here’s what the e-scooter maker plans to...

Offer Exclusively For YouSave up to Rs. 700/-ON...

Flipkart CEO Kalyan Krishnamurthy Asked to Cut Costs as...

During a recent board meeting, Flipkart’s leadership directed CEO...
GdfFD GFD GFD GFD GFD GFD GFD